搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
1 天
Ohio State licenses cancer drug with 'tremendous potential' invented at the James
An experimental drug starting clinical trials next month at Ohio State University's James Cancer Hospital represents a first ...
1 天
on MSN
Nebraska Medicine doctor explains role Omaha plays in cancer research and treatment
November is World Pancreatic Cancer Awareness Month. People around the globe are uniting to shine a light on one of the ...
2 天
UR Medicine highlights screening program during Lung Cancer Awareness Month
November is Lung Cancer Awareness Month, which serves as a good reminder of the resources available locally to help catch the ...
3 天
on MSN
New cancer drug delivery method could boost efficacy of treatment
A spoonful of sugar might actually help the medicine go down, according to recent research from the University of Mississippi ...
Knowridge
1 天
Drug for inflammation treatment may prevent spread of cancer
Most deaths from cancer are caused not by the original tumor but by metastasis—the spread of cancer cells to other parts of ...
3 天
Jazz Pharmaceuticals receives FDA approval for biliary tract cancer treatment
The U.S. Food and Drug Administration approved Jazz Pharmaceuticals' drug, zanidatamab-hrii, for the treatment of a type of ...
GlobalData on MSN
2 天
Novocure secures FDA approval for add-ons to brain cancer treatment wearable
Novocure has refined the transducer arrays that attach to Optune Gio, its wearable for glioblastoma treatment.
Cure Today
2 天
UGN-102 Shows Promising Treatment Responses in Recurrent Bladder Cancer
Treatment with UGN-102 in patients with recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer demonstrated ...
Cure Today
2 天
PSMA-Targeted Radiation Drug for Prostate Cancer Subset Meets Study Goal
Curium aims to collaborate with the FDA for regulatory submission, highlighting their focus on nuclear medicine advancements.
4 天
on MSN
Merck says blockbuster cancer drug met main goals in trial of new under-the-skin formulation
Merck & Co. Inc.’s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈